I do not know how this will play out short term, BUT long term things should look better. They seem to get it, let's now see their actions.
This is exactly what they do with exon skipping.
FDA Commissioner Margaret Hamburg compared the imbalance to the arms of a rower. "We have allowed the arm of regulatory science to become weak and underdeveloped," Hamburg said at a news briefing. If not corrected, "instead of pulling us into an exalted future, we will row in circles."